Monaci Sofia, Strocchi Marina, Rodero Cristobal, Gillette Karli, Whitaker John, Rajani Ronak, Rinaldi Christopher A, O'Neill Mark, Plank Gernot, King Andrew, Bishop Martin J
King's College London, London, United Kingdom.
King's College London, London, United Kingdom.
Comput Biol Med. 2020 Oct;125:104005. doi: 10.1016/j.compbiomed.2020.104005. Epub 2020 Sep 17.
Pace-mapping is a commonly used electrophysiological (EP) procedure which aims to identify exit sites of ventricular tachycardia (VT) by matching ventricular activation patterns (assessed by QRS morphology) at specific pacing locations with activation during VT. However, long procedure durations and the need for VT induction render this technique non-optimal. To demonstrate the potential of in-silico pace-mapping, using stored electrogram (EGM) recordings of clinical VT from implanted devices to guide pre-procedural ablation planning.
Six scar-related VT episodes were simulated in a 3D torso model reconstructed from computed tomography (CT) imaging data, including three different infarct anatomies mapped from infarcted porcine imaging data. In-silico pace-mapping was performed to localise VT exit sites and isthmuses by using 12-lead electrocardiogram (ECG) signals and different combinations of EGM sensing vectors from implanted devices, through the creation of conventional correlation maps and reference-less maps.
Our in-silico platform was successful in identifying VT exit sites for a variety of different VT morphologies from both ECG correlation maps and corresponding EGM maps, with the latter dependent upon the number of sensing vectors used. We also showed the added utility of both ECG and EGM reference-less pace-mapping for the identification of slow-conducting isthmuses, uncovering the optimal algorithm parameters. Finally, EGM-based pace-mapping was shown to be more dependent upon the mapped surface (epicardial/endocardial), relative to the VT origin.
In-silico pace-mapping can be used along with EGMs from implanted devices to localise VT ablation targets in pre-procedural planning.
起搏标测是一种常用的电生理(EP)程序,旨在通过将特定起搏部位的心室激动模式(通过QRS形态评估)与室性心动过速(VT)期间的激动进行匹配,来识别室性心动过速的出口部位。然而,该技术操作时间长且需要诱发室性心动过速,并非最佳选择。本研究旨在利用植入式设备存储的临床室性心动过速的电信号记录来指导术前消融计划,以证明计算机模拟起搏标测的潜力。
在由计算机断层扫描(CT)成像数据重建的三维躯干模型中模拟了6次与瘢痕相关的室性心动过速发作,其中包括从梗死猪成像数据中绘制的三种不同梗死解剖结构。通过创建传统相关图和无参考图,利用12导联心电图(ECG)信号以及植入式设备的不同组合的电信号感知向量,进行计算机模拟起搏标测以定位室性心动过速出口部位和峡部。
我们的计算机模拟平台成功地从心电图相关图和相应的电信号图中识别出各种不同室性心动过速形态的室性心动过速出口部位,后者取决于所使用的感知向量数量。我们还展示了心电图和电信号无参考起搏标测在识别缓慢传导峡部方面的附加效用,揭示了最佳算法参数。最后,相对于室性心动过速起源,基于电信号的起搏标测显示出对映射表面(心外膜/心内膜)的依赖性更强。
计算机模拟起搏标测可与植入式设备的电信号一起用于术前规划中定位室性心动过速消融靶点。